CTKB
#2808
Cytek Biosciences, Inc. - Common Stock
4.6 3 USD
0.00%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+0.22%
Monthly Change
+18.41%
6 month change
-17.91%
Year Change
+40.73%
Previous Close
4.6 2
Open
4.6 3
Low
4.6 2
High
4.6 5
Volume
60
Financials
- Market Capitalization 597.93 M
- Employee 702
- Founded 1992
- CEO N/A
- Website www.cytekbio.com
- Headquarter Delaware, United States
- FIGI BBG00D36Q0Z7
- Industry Medical Devices
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-7.51
Price to sales ratio
2.73
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2750 |  TCMD Tactile Systems Technology, Inc. - Common Stock | 28.67 USD | +3.80% | -5.19% | +8.07% | +194.66% | 646.69 M USD | ||
| 2765 |  CERS Cerus Corporation - Common Stock | 3.17 USD | +3.26% | +2.92% | +24.31% | +133.09% | 635.17 M USD | ||
| 2815 |  BWAY BrainsWay Ltd - American Depositary Shares | 15.14 USD | +4.78% | +0.40% | +6.02% | +22.49% | 592.97 M USD | ||
| 2867 |  NPCE Neuropace, Inc. - Common Stock | 16.33 USD | +3.09% | -2.33% | +5.35% | +54.35% | 556.75 M USD |
Frequently asked questions about Cytek Biosciences, Inc. - Common Stock
What is the Cytek Biosciences, Inc. - Common Stock stock price today?
The current price of Cytek Biosciences, Inc. - Common Stock (CTKB) is 4.63. Over the past 24 hours, the stock has changed by +0.22%. Follow the CTKB chart for real-time price dynamics.
What is the stock ticker of Cytek Biosciences, Inc. - Common Stock?
Cytek Biosciences, Inc. - Common Stock trades under the ticker CTKB. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Cytek Biosciences, Inc. - Common Stock stock going up?
CTKB has changed by +4.75% over the last week, +18.41% over the last month, and +40.73% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Cytek Biosciences, Inc. - Common Stock net income for the last quarter?
Cytek Biosciences, Inc. - Common Stock reported net income of -18.87 M for the last quarter. The previous quarter showed -44.08 M, which means net income changed by +57.20%.
How many employees does Cytek Biosciences, Inc. - Common Stock have?
As of the latest available data, Cytek Biosciences, Inc. - Common Stock has 702 employees. Workforce size can provide additional context about the company's scale and operations.
What is Cytek Biosciences, Inc. - Common Stock EBITDA?
Cytek Biosciences, Inc. - Common Stock EBITDA is -17.05 M, and its EBITDA margin is -38.62%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Cytek Biosciences, Inc. - Common Stock stock?
You can buy Cytek Biosciences, Inc. - Common Stock (CTKB) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Cytek Biosciences, Inc. - Common Stock stock?
Investing in Cytek Biosciences, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CTKB chart and related analysis on metatrader.com as part of your research.